UKHSA's study of PFAS in people's blood: what it covers, and what it could mean here
On 3 November 2026 the BBC reported that the UK Health Security Agency is launching its first study of PFAS levels in people, using blood and urine samples from the Health Survey for England. UKHSA describes it as measuring background exposure in the general population in England; the descriptions cited in this post do not include targeted sampling of communities near contaminated sites. The government has said the PFAS figures will be published after those for other chemicals.
- BBC News, Laura Foster (presenter, Inside Health, BBC Radio 4), ‘Major study into ‘forever chemicals’ in people’s bodies launched in UK’, 3 November 2026: https://www.bbc.co.uk/news/articles/cwly4ejrr72mo
- UK Health Security Agency, ‘UKHSA launches human biomonitoring study’, news story, 10:30 on 3 November 2026: https://www.gov.uk/government/news/ukhsa-launches-human-biomonitoring-study
- UK Health Security Agency, ‘Per- and polyfluoroalkyl substances (PFAS): general information’, published 22 September 2026: https://www.gov.uk/government/publications/pfas-general-information/per-and-polyfluoroalkyl-substances-pfas-general-information
- UK Parliament, written question 36014, asked by Ruth Jones MP on 19 October 2026, answered 26 October 2026: https://questions-statements.parliament.uk/written-questions/detail/2026-10-19/36014
- UK Parliament, written question 37869, asked by Sir Julian Smith MP on 26 October 2026, answered 2 November 2026: https://questions-statements.parliament.uk/written-questions/detail/2026-10-26/37869
- House of Commons Environmental Audit Committee, Addressing the risks from PFAS, HC 852, 23 April 2026, paragraph 65: https://publications.parliament.uk/pa/cm5901/cmselect/cmenvaud/852/report.html
- Government Response to HC 852, HC 519, published 6 July 2026: https://publications.parliament.uk/pa/cm5902/cmselect/cmenvaud/519/report.html
- NHS England, Health Survey for England (description of the survey): https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england
- International Agency for Research on Cancer, news release, 1 December 2023, ‘IARC Monographs evaluate the carcinogenicity of perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS)’: https://www.iarc.who.int/news-events/iarc-monographs-evaluate-the-carcinogenicity-of-perfluorooctanoic-acid-pfoa-and-perfluorooctanesulfonic-acid-pfos/
- GOV.UK site search for ‘PFAS’, ‘forever chemicals biomonitoring’ and ‘Health Survey for England chemicals’, newest items first, about 07:55 on 3 November 2026
Update, 3 November 2026: UKHSA published its own announcement of the study at 10:30 the same morning, after this post went up (UKHSA, 3 November 2026). It says the blood and urine samples from the Health Survey for England will be analysed for PFAS, lead, arsenic, bisphenols, phthalates and flame retardants, and that “Initial findings from UKHSA’s biomonitoring programme are expected in 2027”. It does not say when the PFAS results will be published, which PFAS will be measured, or whether communities near contaminated sites will be sampled separately. It adds that the independent Committee on Toxicity is reviewing the evidence on PFAS and health effects. This post was first published before the announcement; the passages it affects are updated below.
What was reported
On 3 November 2026 BBC News reported that the UK Health Security Agency (UKHSA) is launching its first study of the levels of PFAS (per- and polyfluoroalkyl substances, the “forever chemicals”) in the UK population. The report quotes UKHSA from an interview with BBC Radio 4’s Inside Health (BBC, 3 November 2026). According to the BBC:
- UKHSA will use blood and urine samples collected through the existing Health Survey for England to establish baseline levels of PFAS, lead, arsenic, bisphenols, phthalates and flame retardants.
- The first results are expected next year.
- Dr Edward Wynne-Evans, UKHSA’s director of radiation, chemicals, climate and environmental hazards, said there are gaps around “what different levels of exposure mean for an individual’s long-term health”.
- UKHSA still does not recommend routine PFAS blood tests for individuals, because there is no “established clinical intervention” for raised levels.
The plan was already public. UKHSA’s PFAS page of 22 September 2026 says it “has access to a small number of population samples of blood and urine through the Health Survey for England”, and that analysing them will let it “assess and understand background exposure to PFAS across the general population in England” (UKHSA). The government described the same programme to the Environmental Audit Committee in July 2026 (HC 519; see our national context page). A search of the newest items on GOV.UK at about 07:55 on 3 November 2026 found no announcement of the launch itself. UKHSA published one at 10:30 (see the update above).
When the PFAS figures are due
The BBC reports first results “next year”. A government written answer of 26 October 2026 says the PFAS data will be published after the results for other chemicals:
“Laboratory analysis of background levels of metals, bisphenols, and phthalates has been completed, and the data is currently being processed, with expected publication from early 2027. Publication of data on per- and poly-fluoroalkyl substances and flame retardants will follow at a later stage.”
(written answer 36014, to Ruth Jones MP)
The answer does not name the study the BBC describes; we take them to be the same programme, because both describe UKHSA measuring background levels of these chemicals. Read together, the results due in 2027 may be those for metals, bisphenols and phthalates, with the PFAS figures after them. Neither the BBC report, the 26 October answer nor UKHSA’s announcement gives a date for the PFAS figures.
What it could mean here
A possible comparison for the residents’ results. When 49 Thornton-Cleveleys residents received blood test results in September 2026, the results were reported against US guidance thresholds (our post on the results). In the UK documents we searched for that post (UKHSA’s PFAS pages of 22 September 2026 and Wyre Council’s FOI response of 6 March 2026) we found no reference value for PFAS in blood. Published figures for England could give a comparison with background levels in the population here, if the same chemicals are measured and reported in a comparable way. The BBC report, UKHSA’s PFAS page and its announcement do not say whether PFOA (perfluorooctanoic acid, one of the PFAS) will be reported on its own. A population background level is also a different thing from a guidance threshold: one describes what is typical, the other is a level at which clinical follow-up is suggested.
A study of background levels. The Health Survey for England covers adults and children “living in private households in England” (NHS England), and UKHSA describes the work as measuring background exposure across the general population. The descriptions cited here, including UKHSA’s announcement, do not include targeted sampling of communities near contaminated sites. In April 2026 the Environmental Audit Committee, a committee of MPs, recommended “the establishment of biomonitoring programmes for groups with higher exposure”, and “enhanced health screening” for communities with known or suspected raised PFAS exposure (HC 852, paragraph 65). In its July 2026 response the government repeated that biomonitoring “is not currently recommended through the NHS or private blood tests” and pointed to the background programme (HC 519). The BBC report does not mention targeted testing. Asked on 26 October 2026 what plans there are to monitor PFAS levels in communities in the UK, the government answered on 2 November by referring to the same UKHSA page (written answer 37869).
Individual testing. UKHSA’s published position is unchanged: PFAS biomonitoring (measuring the chemicals in people’s blood or urine) “is not currently recommended for individuals through the NHS or private blood tests” (UKHSA, 22 September 2026).
Health effects. The BBC reports UKHSA’s view that current evidence suggests the possible health impacts associated with PFAS are likely to be limited, with the strongest links in large population groups to raised cholesterol and lower birth weight. That summary is about PFAS as a group. PFOA is one of the PFAS measured in soil around the Hillhouse site (the numbers). The International Agency for Research on Cancer classified PFOA in November 2023 as “carcinogenic to humans” (Group 1) (IARC, 1 December 2023). That classification identifies a cancer hazard. It does not measure the risk at the levels found locally, and it does not show that anyone’s illness was caused by local exposure. The BBC also reports Professor Tony Fletcher of the London School of Hygiene & Tropical Medicine saying that the important thing is to stop ongoing exposure.
What is not confirmed
- UKHSA announced the study on 3 November and expects initial findings from the programme in 2027 (UKHSA). We have not found a detailed study protocol.
- Which PFAS will be measured, how many people’s samples will be tested, and from which survey years.
- When the PFAS results will be published.
- Whether any results will be broken down by area.
- Whether the government will act on the Committee’s recommendation for groups with higher exposure.
We will update this post when UKHSA publishes further details, such as a study protocol, which PFAS will be measured, or when the PFAS results are due.